Circulating Endothelial Cell Levels Correlate with Treatment Outcomes of Splanchnic Vein Thrombosis in Patients with Chronic Myeloproliferative Neoplasms
Circulating endothelial cells (CECs) are viable, apoptotic or necrotic cells, identified by CD 146 surface antigen expression, considered a biomarker of thrombotic risk, given their active role in inflammatory, procoagulant and immune processes of the vascular compartment. Growing evidence establish...
Main Authors: | Giulio Giordano, Mariasanta Napolitano, Michele Cellurale, Paola Di Carlo, Gerardo Musuraca, Giorgia Micucci, Alessandro Lucchesi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/3/364 |
Similar Items
-
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
by: Angela Liu, et al.
Published: (2022-12-01) -
Anticoagulation for Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: The Drug and the Duration
by: Wafik G. Sedhom, et al.
Published: (2021-05-01) -
Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis
by: Sofia Camerlo, et al.
Published: (2023-01-01) -
Transient portal vein thrombosis in liver cirrhosis
by: Xingshun Qi, et al.
Published: (2018-06-01) -
Interventional Approach to Portal Vein Thrombosis and Liver Transplantation: State of the Art
by: Vijay Ramalingam, et al.
Published: (2023-05-01)